Mississauga, ON -- (SBWire) -- 12/06/2016 --AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "XTL Biopharmaceuticals Reports Quarterly Results."

Companies mentioned in this article include XTL Biopharmaceuticals Ltd (NASDAQ:XTLB).

Article Excerpt:

The Pharmaceuticals sector is on a rebound as companies expect various sector friendly changes to be announced by the upcoming Trump administration. Companies with strong product pipelines are expected to perform positively in the coming months as these changes unravel. One such company is XTL Biopharmaceuticals which is engaged in developing treatment for Systemic Lupus Erythematosus or SLE. Its other product candidate is for the treatment of different types of anemias.

This morning, XTL Biopharmaceuticals Ltd (NASDAQ:XTLB) announced their third quarter results as well as provided operational and clinical updates. The company suffered an operating loss of $300,00 for the quarter ended on September 30, while its operating loss for the corresponding quarter of the last year was $396,000. Its total comprehensive loss for the quarter was reported at $0.001 per share.

The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/695/xtl-biopharmaceuticals-reports-quarterly-results.htm

About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.

AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.

Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999.

Investors can receive their free newsletter subscription by clicking here:
http://www.allpennystocks.com/aps_common/newsletter_free.asp

Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: 905-361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com

Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp